Strategy | Financing Highlight Private Placement / Financing Transactions Aviceda Therapeutics: The company raised $64 million of venture funding from undisclosed investors on March 28, 2022. The company is an operator of a biotech business intended to develop...
Strategy | Financing Highlight Private Placement / Financing Transactions Osso VR: The company raised $66 million of Series C venture funding in a deal led by Oak HC/FT on March 24, 2022, putting the company’s pre-money valuation at $158 million. Kaiser...
Strategy | Financing Highlight Private Placement / Financing Transactions Precirix: The company raised EUR 80 million of Series B venture funding in a deal led by Inkef Capital, Jeito, and Forbion on March 16, 2022. Gimv, HealthCap, Novo Holdings, Pontifax Venture...
Strategy | Financing Highlight Private Placement / Financing Transactions TRexBio: The company raised $85 million of Series A venture funding in a deal led by Polaris Partners and Laurion Capital Management on March 8, 2022. Pfizer Ventures, Johnson & Johnson...
Strategy | Financing Highlight Private Placement / Financing Transactions Vesalius Therapeutics: The company raised $75 million of Series A venture funding from Flagship Pioneering on March 1, 2022. The company is a developer of a biotechnology platform intended to...
As the economy incrementally begins to re-open, the Silverwood Partners Healthcare team has considered in the attached analysis (Click here to download) what are expected to be enduring trends in a post-coronavirus environment. We are available for conference video or...